Fulcrum Therapeutics Inc.

4.08
0.08 (2.00%)
At close: Jan 22, 2025, 3:59 PM
4.09
0.12%
After-hours Jan 22, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -97.33M -109.87M -80.85M -70.82M -82.68M -32.59M -22.96M
Depreciation & Amortization 2.17M 2.41M 2.52M 2.38M 2.05M 1.34M 715.00K
Stock-Based Compensation 14.80M 13.35M 11.07M 7.35M 4.22M 2.16M 1.37M
Other Working Capital -3.45M -4.42M -13.61M 7.50M 10.52M 6.54M 596.00K
Other Non-Cash Items -5.99M 152.00K 673.00K -2.00M 25.59M 4.87M 2.59M
Deferred Income Tax n/a n/a n/a 1.93M n/a n/a n/a
Change in Working Capital -4.61M -3.09M -11.89M 7.50M 11.33M 6.52M 804.00K
Operating Cash Flow -90.97M -97.05M -78.48M -53.66M -39.48M -22.56M -20.07M
Capital Expenditures -508.00K -1.96M -1.71M -1.34M -853.00K -8.98M -1.91M
Acquisitions n/a -14.38M 127.96M 55.80M n/a n/a n/a
Purchase of Investments -194.89M -151.15M -216.23M -124.27M n/a n/a n/a
Sales Maturities Of Investments 158.71M 165.53M 88.28M 68.47M n/a n/a n/a
Other Investing Acitivies n/a 14.38M -127.96M -55.80M -91.00K n/a n/a
Investing Cash Flow -36.69M 12.41M -129.67M -57.14M -944.00K -8.98M -1.91M
Debt Repayment n/a n/a -18.00K -50.00K -45.00K -70.00K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 1.55M 3.52M 3.67M 1.24M 215.00K 105.09M 35.28M
Financial Cash Flow 118.12M 84.32M 186.51M 71.13M 64.34M 105.03M 17.66M
Net Cash Flow -9.54M -314.00K -21.64M -39.66M 23.92M 73.48M -4.32M
Free Cash Flow -91.47M -99.01M -80.19M -55.00M -40.34M -31.54M -21.98M

Create Price Alert on FULC

Your price alert will notify you when the stock price is above 4.08.

Add to Watchlist